Sharma Richa, Bansal Sumit, Gangoli Aparna
Department of Pathology, Haroti Diagnostic Centre, Kota, Rajasthan, India.
Department of Urology, Kota Heart Institute and Superspeciality Hospital, Kota, Rajasthan, India.
Indian J Pathol Microbiol. 2024 Oct 1;67(4):939-943. doi: 10.4103/ijpm.ijpm_325_23. Epub 2024 Feb 19.
Lymphoma of the prostate is rare whether it is primary extranodal lymphoma or secondary involvement of the prostate by primary lymphoma elsewhere. Of all the lymphomas of the prostate, primary lymphomas of the prostrate are very rare. Although less frequent, it should be a differential diagnosis when evaluating prostate tumors. Here, we report a case of a 61-year-old man who presented with hematuria with clot retention. A cystoscopy with clot removal and transurethral resection of the prostate (TURP) was performed. This biopsy was sent for histopathological examination at an external center, where a diagnosis of benign prostatic hyperplasia was given. Fifteen days later, the patient presented with hematuria again. On examination, clots were present in the bladder. There was significant prostatomegaly. A re-resection of the prostate was performed and sent for another review to us. The biopsy was reported as high-grade round cell neoplasm, most likely lymphoma. Immunohistochemistry (IHC) was recommended for confirmation. Tumor cells showed immunoreactivity for CD20, B-cell Lymphoma (BCL)-2, BCL-6, Myelocytomatosis (c-Myc), and multiple myeloma 1 (MUM1). Cluster Differentiation (CD)10 was negative. Kiel-67 was high. A final diagnosis of double-expressor diffuse large B-cell lymphoma (DLBCL) of non-germinal center type was made. We share this case to emphasize the fact that primary lymphoma of the prostate is primarily a histopathological diagnosis as the clinical presentation is not unique. Owing to its rarity, the clinical and histopathological suspicion is low. Hence, keeping the differential in mind while evaluating prostate biopsy is beneficial in a timely diagnosis of the entity as the management of prostatic carcinoma and lymphoma is different.
前列腺淋巴瘤很少见,无论是原发性结外淋巴瘤还是其他部位原发性淋巴瘤继发累及前列腺。在所有前列腺淋巴瘤中,原发性前列腺淋巴瘤非常罕见。虽然发病率较低,但在评估前列腺肿瘤时应将其作为鉴别诊断之一。在此,我们报告一例61岁男性患者,其表现为血尿伴血块潴留。进行了膀胱镜下血块清除及经尿道前列腺切除术(TURP)。该活检标本送至外部中心进行组织病理学检查,诊断为良性前列腺增生。15天后,患者再次出现血尿。检查发现膀胱内有血块。前列腺明显肿大。再次进行前列腺切除术,并将标本送我们进行再次检查。活检报告为高级别圆形细胞瘤,很可能是淋巴瘤。建议进行免疫组织化学(IHC)检查以确诊。肿瘤细胞对CD20、B细胞淋巴瘤(BCL)-2、BCL-6、髓细胞瘤(c-Myc)和多发性骨髓瘤1(MUM1)呈免疫反应性。分化簇(CD)10为阴性。增殖细胞核抗原(Ki-67)较高。最终诊断为非生发中心型双表达弥漫性大B细胞淋巴瘤(DLBCL)。我们分享此病例以强调原发性前列腺淋巴瘤主要是一种组织病理学诊断,因为其临床表现并无特异性。由于其罕见性,临床和组织病理学上的怀疑程度较低。因此,在评估前列腺活检时牢记鉴别诊断,有助于及时诊断该疾病,因为前列腺癌和淋巴瘤的治疗方法不同。